{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-027252","form_type":"8-K","ticker":"KYNB","cik":"0000921299","company_name":"KYNTRA BIO, INC.","filed_at":"2023-06-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:42.822015+00:00","generated_at":"2026-06-14T04:33:25.101474+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.15,"confidence":"high","headline":"FibroGen shareholders elect Class III directors, approve say-on-pay and auditor ratification","bullets":["Enrique Conterno, Aoife Brennan, and Gerald Lema elected as Class III directors with 67.4M, 69.2M, and 67.6M votes for, respectively.","Advisory vote on executive compensation passed: 48.7M for, 21.9M against, 89K abstain (31% opposed).","Ratification of PricewaterhouseCoopers as auditor for 2023: 78.5M for, 674K against, 2.2M abstain."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-027252","json":"https://secwatch.observer/filing/0000950170-23-027252.json","markdown":"https://secwatch.observer/filing/0000950170-23-027252.md","text":"https://secwatch.observer/filing/0000950170-23-027252.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/921299/000095017023027252/0000950170-23-027252-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/921299/000095017023027252/fgen-20230607.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T04:33:25.101474+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0d89998926a73839dc1485ade8c7b460427fc1a1","claim":"KYNTRA BIO, INC. shareholders approved Election of Class III directors at the 2023-06-07 meeting.","evidence_excerpt":"(i) Enrique Conterno: 67,436,799 shares of Common Stock voted for, 3,332,142 withheld, and 10,632,221 broker non-votes; (ii) Aoife Brennan, M.B., B.Ch.: 69,182,144 shares of Common Stock voted for, 1,586,797 withheld, and 10,632,221 broker non-votes; and (iii) Gerald Lema: 67,636,643 shares of Common Stock voted for, 3,132,298 withheld, and 10,632,221 broker non-votes.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/921299/000095017023027252/0000950170-23-027252-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-07"}],"fact_type":"shareholder_vote"},{"claim_id":"57951f74718a4cd7a14013bc3ce33d6ff3d3130a","claim":"KYNTRA BIO, INC. shareholders approved Advisory vote on executive compensation at the 2023-06-07 meeting.","evidence_excerpt":"The stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/921299/000095017023027252/0000950170-23-027252-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-07"}],"fact_type":"shareholder_vote"},{"claim_id":"aa76f4e013a9d8a11ae5035e810243d22f3b7148","claim":"KYNTRA BIO, INC. shareholders approved Ratification of PricewaterhouseCoopers LLP as independent registered public accounting firm for fiscal year 2023 at the 2023-06-07 meeting.","evidence_excerpt":"78,505,537 shares of Common Stock voted for, 674,522 against, and 2,221,103 abstaining.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/921299/000095017023027252/0000950170-23-027252-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-07"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}